Question 1

Does AQR Capital Management own BBNX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, AQR Capital Management holds 308,468 shares of BBNX (Beta Bionics), worth $4.8M.

Question 2

How many shares of BBNX does AQR Capital Management own?

Accepted Answer

As of its Q2 2026 13F, AQR Capital Management holds 308,468 shares of BBNX (Beta Bionics).

Question 3

What is AQR Capital Management's BBNX position worth?

Accepted Answer

As of its Q2 2026 13F, AQR Capital Management's BBNX position is worth $4.8M.

Question 4

Is AQR Capital Management buying or selling BBNX?

Accepted Answer

In Q2 2026, AQR Capital Management increased its BBNX position from 60,287 to 308,468 shares.

Question 5

When did AQR Capital Management first buy BBNX?

Accepted Answer

AQR Capital Management first reported BBNX in its Q2 2025 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	308,468	+411.7%	$4.8M	0.0%	$15.67	43
2026-Q1	Increased	60,287	+19.6%	$604,075	0.0%	$11.57	29
2025-Q4	Decreased	50,405	-3.1%	$1.5M	0.0%	$31.97	0
2025-Q3	Decreased	52,010	-6.2%	$1M	0.0%	$19.85	0
2025-Q2	New	55,433	-	$807,105	0.0%	$15.07	34

BBNX5 quarters

BBNX
5 quarters